The efficacy and peripheral blood predictors in recurrent platinum-resistant ovarian cancer patients treated with immune checkpoint inhibitors.

J Ovarian Res · 2025 · PMC12329967 · PMID 40775650

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with positive PD-L1 expression, treated with ICIs at fewer than third line or combined with anti-angiogenic therapy showed a trend of higher DCR although without significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.